Rationale for poly(ADP-ribose) polymerase (PARP) inhibitors in combination therapy with camptothecins or temozolomide based on PARP trapping versus catalytic inhibition (Q33603605)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rationale for poly(ADP-ribose) polymerase (PARP) inhibitors in combination therapy with camptothecins or temozolomide based on PARP trapping versus catalytic inhibition |
scientific article |
Statements
1 reference
Rationale for poly(ADP-ribose) polymerase (PARP) inhibitors in combination therapy with camptothecins or temozolomide based on PARP trapping versus catalytic inhibition (English)
1 reference
Yves Pommier
1 reference
Junko Murai
1 reference
Yiping Zhang
1 reference
Joel Morris
1 reference
Jiuping Ji
1 reference
James H Doroshow
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference